Researchers use cryo-EM and optical tweezers to investigate how an antiviral interacts with the herpes simplex virus.

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...